Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults (NCT07539987)
🩺 Plain-English Summary (8th-Grade Level)
Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascular disease, and the older adult population in the United States is rapidly growing. Given the converging threats of worsening air quality and an aging population, this clinical trial will evaluate a novel, multifaceted indoor air quality intervention to improve cardiovascular health outcomes among older adults in the wildfire-impacted state of Montana.
Who can join: Review the eligibility criteria below.
Location: University of Montana — Missoula, Montana
Age range: 55 Years to 79 Years
🧪 Interventions in This Study
- Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE) (BEHAVIORAL)
- Portable Air Cleaner (PAC) Control (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Montana — Missoula, Montana
📞 Contact the Study Coordinator
Phone: (406) 243-2063
Email: ethan.walker@umontana.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiovascular Diseases
- The Jackson Heart Study of Cardiovascular Disease Among African Americans — Jackson, Mississippi
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials — Toronto, Ontario
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study — Ottawa, Ontario
- Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption — Davis, California
- Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring — Arlington, Texas
- Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) — Baltimore, Maryland
Explore by condition: All Cardiovascular Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.